Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF OCTOBER 19, 2024 SAM #8362
SOLICITATION NOTICE

Q -- Serological Assays for the detection and characterization of influenza viruses

Notice Date
10/17/2024 4:59:00 AM
 
Notice Type
Presolicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
 
ZIP Code
30333
 
Solicitation Number
75D30125R73211
 
Archive Date
03/20/2025
 
Point of Contact
Jennifer Gartzke, Phone: 4044980020
 
E-Mail Address
jgartzke@cdc.gov
(jgartzke@cdc.gov)
 
Small Business Set-Aside
SBA Total Small Business Set-Aside (FAR 19.5)
 
Description
This contract is for one 12-month base period, and four, 12-month option periods for the testing of immunological responses of human samples collected from vaccine effectiveness studies of seasonal and pandemic influenza vaccine, randomized controlled trials of influenza vaccines, and/or outbreak investigations using HAI assay.� The testing of human samples will be done in batches and is dependent upon completion of studies or outbreak investigations.� The government will provide the schedules for the delivery of the study samples at contract award, if samples are already collected, or two months prior to the study completion.� The government will provide standard operating procedures (SOPs) for assay creation to the contractor.� The government will also provide two proficiency panels per each period of performance, within the contract performance period as well as positive and negative controls to the contractor, to confirm proper assay performance by contractor technicians.� Samples will be evaluated using government furnished seasonal influenza viruses and/or antigens.�In addition to the core requirement above, the contract also consists of an optional task for the development and validation of a new serology assay comparable to HAI.� The government will provide positive and negative controls to the contractor as well as seasonal influenza viruses and/or antigens to validate assay and compare its sensitivity and specificity against HAI.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/84e018421ede492b8b79bd974764c756/view)
 
Place of Performance
Address: Atlanta, GA, USA
Country: USA
 
Record
SN07242527-F 20241019/241017230105 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.